Document ID: chunk:federal_register_of_legislation:C2004A00739:clause:2_100b
Version: federal_register_of_legislation:C2004A00739
Segment Type: clause
Provision Reference: sch 2 cl 100B
Character Range: 42714–44138

100B  Appointment etc. of members of the Pharmaceutical Benefits Advisory Committee

 (1) The members of the Pharmaceutical Benefits Advisory Committee are to be appointed by the Minister by written instrument.

 (1A) A person appointed under subsection 100A(3) must be appointed from nominations made by the following bodies:
 (a) in respect of paragraph 100A(3)(a)—consumer organisations;
 (b) in respect of paragraph 100A(3)(b)—professional associations of health economists;
 (c) in respect of paragraph 100A(3)(c)—professional associations of pharmacists;
 (d) in respect of paragraph 100A(3)(d)—professional associations of medical practitioners;
 (e) in respect of paragraph 100A(3)(e)—professional associations of clinical pharmacologists;
 (f) in respect of paragraph 100A(3)(f)—professional associations of specialists;
prescribed by the regulations for the purposes of this subsection.

 (1B) The regulations may prescribe matters relating to nominations, including (but not limited to) the number of nominations to be considered by the Minister before making an appointment.

 (2) A member of the Committee is eligible for reappointment.

 (3) The exercise or performance of the functions and powers of the Committee is not affected only because there is a vacancy in the office of a member of the Committee.

 (4) The names and qualifications of the members of the Committee must be published in the Gazette.